Gilead Sciences Inc Cash Flow Reinvestment Rate
Gilead Sciences Inc cash flow reinvestment rate. Gilead Sciences Inc (GILD) has a Cash Flow Reinvestment Rate of 0.31x as of June 2026, reinvesting $1.10 Billion (capex $117.00 Million plus investments $983.00 Million) from operating cash flow of $3.57 Billion. Explore debt repayment capacity of Gilead Sciences Inc to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Gilead Sciences Inc (2002–2025)
Cash flow reinvestment rate of Gilead Sciences Inc from 2002 to 2025. Historical reinvestment intensity for Gilead Sciences Inc across 24 annual periods. Explore GILD capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Gilead Sciences Inc Cash Flow Reinvestment Rate by Year (2002–2025)
Gilead Sciences Inc cash flow reinvestment rate by year from 2002 to 2025. Year-by-year capital reinvestment analysis for Gilead Sciences Inc. For the full cash flow conversion analysis, see how efficiently does Gilead Sciences Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | $3.73 Billion | $10.02 Billion | $563.00 Million | ▲ +1.4% |
| 2024 | 0.37x | $3.97 Billion | $10.83 Billion | $523.00 Million | ▲ +17.6% |
| 2023 | 0.31x | $2.50 Billion | $8.01 Billion | $585.00 Million | ▼ -11.4% |
| 2022 | 0.35x | $3.19 Billion | $9.07 Billion | $728.00 Million | ▲ +8.0% |
| 2021 | 0.33x | $3.71 Billion | $11.38 Billion | $579.00 Million | ▼ -78.9% |
| 2020 | 1.54x | $12.60 Billion | $8.17 Billion | $650.00 Million | ▲ +350.3% |
| 2019 | 0.34x | $3.13 Billion | $9.14 Billion | $825.00 Million | ▼ -82.2% |
| 2018 | 1.93x | $16.20 Billion | $8.40 Billion | $924.00 Million | ▲ +306.7% |
| 2017 | 0.47x | $5.64 Billion | $11.90 Billion | $590.00 Million | ▼ -32.5% |
| 2016 | 0.70x | $11.98 Billion | $17.05 Billion | $748.00 Million | ▲ +19.8% |
| 2015 | 0.59x | $12.47 Billion | $21.25 Billion | $747.00 Million | ▲ +312.8% |
| 2014 | 0.14x | $1.82 Billion | $12.82 Billion | $557.00 Million | ▼ -12.6% |
| 2013 | 0.16x | $505.07 Million | $3.10 Billion | $190.00 Million | ▼ -52.5% |
| 2012 | 0.34x | $1.09 Billion | $3.19 Billion | $397.00 Million | ▼ -71.9% |
| 2011 | 1.22x | $4.44 Billion | $3.64 Billion | $131.90 Million | ▲ +87.3% |
| 2010 | 0.65x | $1.85 Billion | $2.83 Billion | $61.88 Million | ▲ +107.3% |
| 2009 | 0.31x | $968.08 Million | $3.08 Billion | $230.06 Million | ▲ +485.8% |
| 2008 | 0.05x | $115.00 Million | $2.14 Billion | $115.00 Million | ▲ +20.4% |
| 2007 | 0.04x | $78.65 Million | $1.77 Billion | $78.65 Million | ▼ -48.4% |
| 2006 | 0.09x | $105.21 Million | $1.22 Billion | $105.21 Million | ▲ +27.1% |
| 2005 | 0.07x | $47.95 Million | $705.64 Million | $47.95 Million | ▼ -32.8% |
| 2004 | 0.10x | $51.37 Million | $507.96 Million | $51.37 Million | ▼ -38.6% |
| 2003 | 0.16x | $38.61 Million | $234.61 Million | $38.61 Million | ▼ -30.4% |
| 2002 | 0.24x | $17.60 Million | $74.41 Million | $17.60 Million | — |